Cell Therapy in ARDS and Sepsis

The classification and biology of investigational cell therapies

The lecture duration is 49min.

1 CPD Point, 1 CEU, 1 CME credit approval pending.
Accredited by CPDUK, CBRN and Provider Pending.

You can watch this lecture for free! For premium features, including a CPD/CME accredited certificate, to use time-coded note taking or get downloadable slides, you will need a fair price subscription.

Sign In or Sign Up For Free to access this lecture.
Jonathan Millar
Clinical Lecturer, Intensive Care Medicine, Roslin Institute, University of Edinburgh
Lecture Summary

In the last five years, the introduction of cellular therapies has revolutionized the management of haematological cancers. The success of this approach has encouraged others to seek novel means to treat a variety of critical illness syndromes. In this talk, we will review the current state of cell-based immune modulation for ARDS and sepsis. We will address the classification and biology of investigational cell therapies, alongside a discussion of the challenges associated with scaling them for widespread clinical use.

Target Audience

Critical Care Doctors
Experienced or advanced Critical Care Nurses

Learning Objectives:

Upon completion of this activity, you should be able to:

  • Appreciate the spectrum of available cellular therapies
  • Describe the biology of cell therapies in the context of critical illness
  • Discuss the current evidence base for cell therapies and be aware of important ongoing trials
  • Understand the challenges associated with delivering cell therapy in the clinic